Safety and tolerability of empagliflozin in patients with type 2 diabetes

Sven Köhler, Afshin Salsali, Stefan Hantel, G Kim, HJ Woerle, UC Broedl

Diabetologie und Stoffwechsel · 2016 · 14 citations · 0 references

Abstract

Aim: To assess the safety and tolerability of empagliflozin using data pooled from Phase I, II and III trials in patients with type 2 diabetes (T2DM).